Parkside Financial Bank & Trust’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39K Hold
25
﹤0.01% 2235
2025
Q4
$1.21K Hold
25
﹤0.01% 2275
2025
Q3
$766 Hold
25
﹤0.01% 2384
2025
Q2
$555 Buy
+25
New +$523 ﹤0.01% 2482

Other funds holding ANAB

Parkside Financial Bank & Trust's ANAB Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its AnaptysBio (ANAB) position steady in Q1 2026 at 25 shares worth $1.39K. The position accounts for ﹤0.01% of the portfolio, ranked #2235.

Parkside Financial Bank & Trust first reported a position in ANAB in Q2 2025 and has held it in 4 quarters since. 208 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • Parkside Financial Bank & Trust held 25 shares of AnaptysBio worth $1.39K as of Q1 2026.
  • Parkside Financial Bank & Trust left its AnaptysBio share count unchanged in Q1 2026.
  • AnaptysBio made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2235 holding.
  • Parkside Financial Bank & Trust first reported a position in AnaptysBio in Q2 2025 and has held it in 4 quarters since.
  • 208 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.